Category:
Prophylactic Biological Products
CAS NO:
NA
Standard:
In-house Standards,
Oyster Peptide Composite Tablets are pharmaceutical formulations containing hydrolyzed oyster peptides. The core process involves enzymatic hydrolysis followed by tablet compression. Molecular formula and CAS number remain undefined for this specific composite blend as it is a proprietary mixture rather than a single chemical entity.
Contraindicated for individuals with shellfish allergies. Store in a cool, dry place below 25°C to prevent moisture absorption and degradation of peptide activity. Do not exceed recommended daily dosage.